7/29/2019 Financial report, MDACC
1/17
Financial Report &
Clinical Activity Update
Clinical Department ChairsDecember 17, 2012
7/29/2019 Financial report, MDACC
2/17
November 2012
Clinical Activity Update
7/29/2019 Financial report, MDACC
3/17
FY 2012 Professional New Patient &
Consultation Billed VisitsActual vs. Budget
3
Actual Budget Variance % Variance Actual Budget Variance % Variance
Cancer Medicine 2,060 2,179 (119) (5.5%) 6,217 6,567 (350) (5.3%)
DoCP & PS - Clinical 299 322 (23) (7.1%) 896 940 (44) (4.7%)
Internal Medicine 1,974 2,151 (177) (8.2%) 6,302 6,271 31 0.5%
Pediatrics 60 73 (13) (17.8%) 193 223 (30) (13.5%)
Surgery 2,478 2,665 (187) (7.0%) 7,453 7,912 (459) (5.8%)
Total 6,871 7,390 (519) (7.0%) 21,061 21,913 (852) (3.9%)
FY 2013 - November YTDFY 2013 -November
7/29/2019 Financial report, MDACC
4/17
FY 2012 Professional New Patient &
Consultation Billed VisitsActual vs. Budget
Cancer Medicine
4
Actual Budget Variance % Variance Actual Budget Variance % Variance
Gynecologic Medical Oncology 2 2 - 0.0% 3 5 (2) (40.0%)
Stem Cell Transplantation 178 163 15 9.2% 483 488 (5) (1.0%)
Lymphoma/Myeloma 188 204 (16) (7.8%) 553 592 (39) (6.6%)
Leukemia 160 164 (4) (2.4%) 458 464 (6) (1.3%)
Sarcoma Medical Oncology 56 88 (32) (36.4%) 213 280 (67) (23.9%)
Neuro-Oncology 151 142 9 6.3% 434 431 3 0.7%
Thoraci c/ Head & Neck Medi cal Oncol ogy 268 263 5 1.9% 776 785 (9) (1.1%)
Palliative Care&Rehabilitation Medicine 99 138 (39) (28.3%) 314 415 (101) (24.3%)
Melanoma Medical Oncology 58 76 (18) (23.7%) 214 236 (22) (9.3%)
Investigational Cancer Therapeutics 128 125 3 2.4% 354 403 (49) (12.2%)General Oncology 63 71 (8) (11.3%) 229 211 18 8.5%
GI Medical Oncology 281 302 (21) (7.0%) 849 927 (78) (8.4%)
Genitourinary Medical Oncology 152 177 (25) (14.1%) 486 554 (68) (12.3%)
Breast Medical Oncology 276 264 12 4.5% 851 776 75 9.7%
Cancer Medicine 2,060 2,179 (119) (5.5%) 6,217 6,567 (350) (5.3%)
FY 2013 - November YTDFY 2013 - November
7/29/2019 Financial report, MDACC
5/17
FY 2012 Professional New Patient &
Consultation Billed VisitsActual vs. Budget
Cancer Prevention
5
Actual Budget Variance % Variance Actual Budget Variance % Variance
Clinical Cancer Prevention - Clinical 299 322 (23) (7.1%) 896 940 (44) (4.7%)
DoCP & PS - Clinical 299 322 (23) (7.1%) 896 940 (44) (4.7%)
FY 2013 - November YTDFY 2013 - November
7/29/2019 Financial report, MDACC
6/17
FY 2012 Professional New Patient &
Consultation Billed VisitsActual vs. Budget
Internal Medicine
6
Actual Budget Variance % Variance Actual Budget Variance % Variance
Infectious Diseases/Infection Control/EH 72 81 (9) (11.1%) 226 243 (17) (7.0%)
General Internal Medicine 502 493 9 1.8% 1,644 1,504 140 9.3%
Cardiology 201 209 (8) (3.8%) 577 600 (23) (3.8%)Endocrine Neoplasia & HD 225 247 (22) (8.9%) 769 778 (9) (1.2%)
Dermotology 421 518 (97) (18.7%) 1,423 1,396 27 1.9%
Pulmonary Medicine Dept 249 239 10 4.2% 662 735 (73) (9.9%)
Gas troenterol ogy, Hepatol ogy & Nutri ti on 304 364 (60) (16.5%) 1,001 1,015 (14) (1.4%)
Internal Medicine 1,974 2,151 (177) (8.2%) 6,302 6,271 31 0.5%
FY 2013 - November YTDFY 2013 - November
7/29/2019 Financial report, MDACC
7/17
FY 2012 Professional New Patient &
Consultation Billed VisitsActual vs. Budget
Pediatrics
7
Actual Budget Variance % Variance Actual Budget Variance % Variance
Dept of Clinical Pediatrics 60 73 (13) (17.8%) 193 223 (30) (13.5%)
Pediatrics 60 73 (13) (17.8%) 193 223 (30) (13.5%)
FY 2013 - November YTDFY 2013 - November
7/29/2019 Financial report, MDACC
8/17
7/29/2019 Financial report, MDACC
9/17
New Patient & Consult Visits
9
5,8325,935
6,318
7,686 7,242
6,9656,758
6,545
7,260 6,612 7,0296,894
0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
9,000
Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12
Prior Year Actual (Rolling 12 Months)
7/29/2019 Financial report, MDACC
10/17
New Patient & Consult Visits
10
6,217
6,680 6,736
7,6057,283 7,412 7,412
7,115
7,460
7,073
7,450
7,390
5,8325,935
6,318
7,686 7,242
6,9656,758
6,545
7,260 6,612 7,0296,894
0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
9,000
Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12
Budget (Rolling 12 Months)
Prior Year Actual (Rolling 12 Months)
7/29/2019 Financial report, MDACC
11/17
7/29/2019 Financial report, MDACC
12/17
Average Daily Census
499491
497
486484
524
503498
504
481
512
500
485
498
473
479
463
531 531
545
513
500
524
517
532
506
522
505
547554
527 527
553
559
545
548
544542
558
588
552558
556
534507
517521
571576577
588
601603
609607 611
617 619624
631 630631
400
450
500
550
600
650
Sep-0
9
Oct-09
N
ov-0
9
Dec-0
9
Jan-1
0
Feb-1
0
M
ar-10
Apr-10
M
ay-1
0
Jun-1
0
Jul-10
Aug-1
0
Sep-1
0
Oct-10
N
ov-1
0
Dec-1
0
Jan-11
Feb-1
1
M
ar-11
Apr-11
M
ay-11
Jun-1
1
Jul-11
Aug-1
1
Sep-1
1
Oct-11
N
ov-1
1
Dec-1
1
Jan-1
2
Feb-1
2
M
ar-12
Apr-12
M
ay-1
2
Jun-1
2
Jul-12
Aug-1
2
Sep-1
2
Oct-12
N
ov-1
2
Dec-1
2
FY 2010 FY 2011 FY 2012 FY 2013
Census
Census Budget
Operating Beds
Source: Institutional Dashboard
as of
12/15/12
7/29/2019 Financial report, MDACC
13/17
FY 2013 YTD November
Financial Report
7/29/2019 Financial report, MDACC
14/17
In Millions Actual Budget VarianceFY 2013 FY 2013 Favorable % Favorable/
Nov YTD Nov YTD (Unfavorable) Unfavorable
Total Net Patient Revenue 731.1$ 784.4$ (53.3)$ -6.8%
Total Other Operating Revenue 119.5 119.3 0.2 0.2%
Total Operating Revenue 850.6 903.7 (53.1) -5.9%
Personnel Expense 507.1 513.9 6.8 1.3%
All Other Operating Expense 362.1 368.3 6.2 1.7%
Total Operating Expense 869.3 882.3 13.0 1.5%
Total Operating Income/(Loss) (18.6) -2.2% 21.5 2.4% (40.1) -186.7%
State Appropriations/Tobacco Settlement 40.8 40.7 0.0 0.1%
Restricted & Designated Gifts 27.1 14.1 13.0 92.4%
Investment Income 22.8 19.6 3.1 16.0%
Change in Market Value 16.6 18.4 (1.8) -9.9%
Total Non-Operating Revenue 107.2 92.9 14.4 15.5%
Net Income/(Loss) 88.6$ 9.3% 114.3$ 11.5% (25.7)$ -22.5%
14
FY 2012 Statement of OperationsActual vs. Budget
7/29/2019 Financial report, MDACC
15/17
In Millions Actual ActualFY 2013 FY 2012 Increase % Increase/
Nov YTD Nov YTD (Decrease) Decrease
Total Net Patient Revenue 731.1$ 702.3$ 28.8$ 4.1%
Total Other Operating Revenue 119.5 112.1 7.5 6.7%
Total Operating Revenue 850.6 814.4 36.2 4.5%
Personnel Expense 507.1 467.5 39.7 8.5%
All Other Operating Expense 362.1 321.8 40.4 12.5%
Total Operating Expense 869.3 789.2 80.0 10.1%
Total Operating Income/(Loss) (18.6) -2.2% 25.2 3.1% (43.8) -174.0%
State Appropriations/Tobacco Settlement 40.8 41.5 (0.7) -1.8%
Restricted & Designated Gifts 27.1 12.7 14.4 113.3%
Investment Income 22.8 20.4 2.4 11.6%
Change in Market Value 16.6 (44.0) 60.6 137.7%
Total Non-Operating Revenue 107.2 30.7 76.6 249.7%
Net Income/(Loss) 88.6$ 9.3% 55.8$ 6.6% 32.8$ 58.7%
15
FY 2012 Statement of OperationsActual vs. Actual
7/29/2019 Financial report, MDACC
16/1716
Operating Revenue & Expense
Growth Rates
8.5%
8.1%7.0%
9.3%
8.4%
4.1%
8.6% 8.5%
6.7%
10.0%
7.4%
4.5%
10.5%
6.2%
0.8%
8.8%
7.5%
8.5%
9.8%
5.7%
2.4%
8.5%
9.2%
10.1%
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%
12.0%
FY 2008 FY 2009 FY 2010 FY 2011 FY 2012 FY 2013 YTD Nov
Net Patient Revenue
Total Operating Revenue
Personnel Expense
Total Operating Expense
7/29/2019 Financial report, MDACC
17/17
Top Related